Cited by 324Epilepsy research and treatmentStatistical Methods in EpidemiologyPharmacological Effects and Toxicity Studies

The DOI matches its Crossref record, with a small difference in title or year; 13 of the 14 references it cites were found in a registry or an index.

Estimating risk for developing epilepsy: A population-based study in Rochester, Minnesota

Open access

Abstract

OBJECTIVES: Previous studies that have assessed the risk of developing epilepsy have failed to account for the competing risk of death, significant in the elderly where epilepsy incidence is highest. We report the lifetime risk for epilepsy, accounting for the competing risk of mortality. METHODS: Lifetime risk and cumulative incidence of epilepsy were examined among Rochester, MN, residents between 1960 and 1979. Age-, gender-, and calendar year-specific deaths were obtained for Rochester, MN. Lifetime risk was calculated as the conditional probability of developing epilepsy by a specific age for a person reaching that age who had not yet developed epilepsy. Lifetime risk and cumulative incidence were compared for age and time period. RESULTS: We identified 412 individuals with incident epilepsy diagnosed between January 1, 1960, and December 31, 1979. Lifetime risk was 1.6% to age 50 and 3.0% to age 80; cumulative incidence was 1.7% to age 50 and 3.4% to age 80. Similar differences were seen across epilepsy etiologies. Lifetime risk through 87 years of age increased over time from 3.5% in 1960-1969 to 4.2% in 1970-1979. CONCLUSIONS: One in 26 people will develop epilepsy during their lifetime. Lifetime risk provides an estimate of an individual's risk for epilepsy over his or her remaining lifetime, translates into the number of people who are expected to develop epilepsy, and assists health care planners as they estimate service needs for epilepsy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0b013e318204a36a

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Cited by

Sorted by citations

See all 324

Metadata

Authors
Hesdorffer, D. C., Logroscino, G., Benn, E. K. T., Katri, N., Cascino, G., & Hauser, W. A.
Affiliations
Mayo Clinic (US)
Venue
Neurology
Published
2011-01-04
Volume
76
Issue
1
Pages
23-27
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2064064788
Cited by
324
References
14
Citations by year
2026: 18 · 2025: 18 · 2024: 20 · 2023: 25 · 2022: 22 · 2021: 34 · 2020: 24 · 2019: 20 · 2018: 22 · 2017: 23 · 2016: 26 · 2015: 19 · 2014: 17 · 2013: 9 · 2012: 17
FWCI
7.74
Type
journal article
Language
en
Open access
Locations
  • Neurology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Pfizer
  • Association of American Medical Colleges
  • University of Minnesota
  • NeuroPace
  • Ministero della Salute
  • H. Lundbeck A/S
  • National Institutes of Health (NS043209)
  • Centers for Disease Control and Prevention (DP002209)
  • National Institute of Neurological Disorders and Stroke (NS043209, T32NS007153, NS07153, P50NS016308)
  • National Center for Research Resources (MO1 RR00645, M01RR000645)
  • Maternal and Child Health Bureau
Topics
  • Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Epidemiology
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
Keywords
epilepsy, lifetime risk, cumulative incidence, competing risk of death, older adults, Rochester, Minnesota, epilepsy etiology, health planning
MeSH terms
Age Factors, Aged, Aged, 80 and over, Epilepsy, Female, Humans, Male, Middle Aged, Minnesota, Predictive Value of Tests, Probability, Retrospective Studies, Risk Factors, Sex Factors, Incidence, Community Health Planning

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review